Key result
Micro-structured polycarbonate-urethane surfaces with small groove widths (~3 μm) reduced platelet activation and adhesion compared to plain surfaces or distinct wave structures (~90 μm).
Why the study?
Does surface micro-structuring of polycarbonate-urethane reduce platelet activation and adhesion in contact with blood?
Does surface micro-structuring of polycarbonate-urethane reduce platelet activation and adhesion in contact with blood?
Micro-structuring of polycarbonate-urethane surfaces, specifically with small groove widths, reduces platelet activation and adhesion, suggesting improved hemocompatibility for heart valve models.
Answers are grounded in this paper and cite their sources.
May enhance hemocompatibility of polycarbonate-urethane devices; hypothesis-generating and requires in vivo validation before clinical consideration.
In the development of new hemocompatible biomaterials, surface modification appears to be a suitable method in order to reduce the thrombogenetic potential of such materials. In this study, polycarbonate-urethane (PCU) tubes with different surface microstructures to be used for aortic heart valve models were investigated with regard to the thrombogenicity. The surface structures were produced by using a centrifugal casting process for manufacturing PCU tubes with defined casting mold surfaces which are conferred to the PCU surface during the process. Tubes with different structures defined by altering groove widths were cut into films and investigated under dynamic flow conditions in contact with porcine blood. The analysis was carried out by laser scanning microscopy which allowed for counting various morphological types of platelets with regard to the grade of activation. The comparison between plain and shaped PCU samples showed that the surface topography led to a decline of the activation of the coagulation cascade and thus to the reduction of the fibrin synthesis. Comparing different types of structures revealed that smooth structures with a small groove width (d ~ 3 μm) showed less platelet activation as well as less adhesion in contrast to a distinct wave structure (d ~ 90 μm). These results prove surface modification of polymer biomaterials to be a suitable method for reducing thrombogenicity and hence give reason for further alterations and improvements.
No takes yet. Share an insight, caveat, or question.
Clauser et al. (2014) studied Thrombogenicity of biomaterials. Micro-structured polycarbonate-urethane (PCU) surfaces vs. Plain PCU surfaces and distinct wave structures was evaluated on Platelet activation, adhesion, and fibrin synthesis. Micro-structured polycarbonate-urethane surfaces with small groove widths (~3 μm) reduced platelet activation and adhesion compared to plain surfaces or distinct wave structures (~90 μm).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: